Extra medication for amoebic liver abscess treatment
Part of Digestive system, Infections clinical trials.
This study tests whether adding a second medicine (diloxanide furoate) to the standard antibiotic (metronidazole) helps people recover from an amoebic liver abscess. If you have this condition and are otherwise healthy, this treatment might improve your recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are older than 18 years.
- You have been newly diagnosed with an amoebic liver abscess.
- You can take medicines by mouth.
- You have not taken antibiotics for more than 3 days before joining the study.
- You are not pregnant.
- You are not currently taking blood thinners (like antiplatelets or anticoagulants).
- You do not have serious complications like shock, breathing problems, kidney issues, confusion, cancer, or HIV.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two antibiotic treatments for liver abscess: one given through an IV (into a vein) and one taken as pills by mouth. The goal is to see if the oral treatment works just as well, which could make treatment easier and more convenient for patients.
This trial tests whether lowering ammonia levels with medications can prevent serious liver-related problems in people with acute-on-chronic liver failure who do not yet have confusion. Participation involves receiving medication to reduce ammonia, which may help avoid complications.
This study compares two strong antibiotics to see which one works better for people with liver failure who get a hospital-acquired infection caused by resistant bacteria. The two drugs are ceftazidime-avibactam and a higher dose of meropenem given as an extended infusion.
This trial tests a new combination of antibiotics to treat a hard-to-cure lung infection caused by Mycobacterium abscessus. It compares the new combination to the standard treatment, and people with cystic fibrosis and those without can take part.
This trial tests if paromomycin or metronidazole works better for adults with ongoing stomach problems caused by a parasite called Dientamoeba fragilis. These symptoms (pain, bloating, diarrhea) must have lasted more than a month, and no other cause has been found.
This trial tests a new treatment using a light-activated dye (methylene blue) that is injected into deep abscesses during normal drainage. The goal is to kill bacteria and reduce infection. This might help people who need drainage for a deep abscess, by possibly speeding recovery or improving outcomes.
Hear when a new Liver Abscess trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.